Darier-White disease (DD) first came to the attention of dermatologists in the late 1800s -- indeed, the condition carries the name of two prominent dermatologists of the time -- and is characterized by scores of itchy, smelly, scaly bumps covering much of the skin. This inherited disease is physically and socially debilitating and incurable. Although researchers have been able to map the gene responsible to a chromosomal region, its identity has, until now, remained elusive.
The upper layer of the skin (epidermis) is composed of neat and organized layers of cells called keratinocytes. These are held in place through specialized points of contact -- comprised of structures called desmosomes and adherens junctions -- with neighbouring cells. In DD, the connections between the cells are lost and the structural integrity of the skin wall crumbles, leading to 'bumpy' skin lesions. Alain Hovnanian (of the Wellcome Trust Centre for Human Genetics) and colleagues now report that mutations in the SERCA2 gene, which encodes a calcium pump, are the cause of DD. The SERCA2 calcium pump is located inside keratinocytes and drives calcium ions into a cellular compartment called the endoplasmic reticulum. This shuttling of calcium ions regulates numerous biological pathways involved in growth and differentiation. In DD patients, whose SERCA2 pump is defective, the calcium balance within the cell is disrupted, leading to the disorganized growth of the epidermis.
The symptoms of DD are further aggravated by heat, sweating, sunlight and stress. As discussed by Monica Peacocke and Angela Christiano (of Columbia University) in an accompanying News & Views article, this may provide clues to environmental agents that regulate calcium homeostasis within skin cells. In addition, Peacocke and Christiano explain how disruption of the intricate scaffolding and cellular communications within the epidermis can lead to disorders of the skin.
Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier diseasepp 271 - 277 Anavaj Sakuntabhai, Victor Ruiz-Perez, Simon Carter, Nick Jacobsen, Susan Burge, Sarah Monk, Melanie Smith, Colin S. Munro, Michael O'Donovan, Nick Craddock, Raju Kucherlapati, Jonathan L. Rees, Mike Owen, G. Mark Lathrop, Anthony P. Monaco, Tom Strachan & Alain Hovnanian doi:10.1038/6784 Abstract|Full
text|PDF
Bumps and pumps, SERCA 1999pp 252 - 253 Monica Peacocke & Angela M. Christiano doi:10.1038/6758 Abstract|Full
text|PDF
The brewers' and bakers' yeast Saccharomyces cerevisiae was the first eukaryotic organism whose genome was fully sequenced. Using an ingenious functional genomics approach, Guri Giaever, Ron Davis (Stanford University) and colleagues now report that they can use yeast to identify drugs -- and drug targets -- which could eventually help sick humans.
Like human cells, yeast cells are diploid -- that is, they have two copies of every gene. For the most part, human and yeast cells can live happily with only one intact copy of a given gene. For some genes, however, losing one of the two copies leads to a detectable difference, a change in phenotype. This state is termed 'haplo-insufficiency'; one copy is not enough to sustain normal, healthy life. Giaever and colleagues used a method for systematically deleting one copy of each of the yeast's 6,000 genes and, to distinguish the different mutants, they labelled each mutant strain with a molecular 'bar code'.
When the researchers challenged a mixture of such mutant yeast strains with drugs, they observed haploinsufficiency -- some yeast strains failed to thrive in the presence of the drug (most drugs target key regulator proteins, and it seems that for many of them, the amount is critical to growth). These 'drop-outs' were identified by the disappearance of particular bar codes from the mixture, allowing researchers to identify genes corresponding to protein targets of the drugs. In this pilot study, Giaever and co-workers validated six known drug targets and identified two new candidates.
Stephen Oliver (University of Manchester Institute of Science and Technology) explains in an accompanying News & Views article that while the technique demonstrated by Giaever and co-workers is particularly suited to identifying drugs that act on proteins encoded by essential yeast genes (likely targets of anti-fungal drugs), it is not limited to exploring yeast biology. The striking conservation of protein sequences between yeast and humans -- together with the possibility of introducing human genes into yeast -- should allow the identification of drug targets for a wide range of genes involved in human diseases.
Genomic profiling of drug sensitivities via induced haploinsufficiencypp 278 - 283 Guri Giaever, Daniel D. Shoemaker, Ted W. Jones, Hong Liang, Elizabeth A. Winzeler, Anna Astromoff & Ronald W. Davis doi:10.1038/6791 Abstract|Full
text|PDF
Redundancy reveals drugs in actionpp 245 - 246 Stephen Oliver doi:10.1038/6748 Abstract|Full
text|PDF
The human genome is littered with the remnants of foreign DNA fragments, called retrotransposons, which have 'invaded' it over time. When retrotransposons first 'colonized' the human genome, many were able to replicate and 'jump' (retrotranspose) to other sites and, in some cases, they inserted into critical genes of the host, resulting in diseases such as haemophilia and breast cancer. Over time, however, these fragments have mutated and become rearranged such that the full complement of genes needed for retrotransposition has been lost, and the elements remain 'stranded' at their site of insertion. Eckart Meese, Jens Mayer (of the University of the Saar) and colleagues have now identified the first virtually intact retrotransposon in the human genome. It contains most of the genes needed for retrotransposing activity and -- while it remains to be demonstrated whether this element is actually capable of 'jumping' -- it raises the possibility that retrotranposons may still be shifting through the sands of the human genome.
An almost-intact human endogenous retrovirus K on human chromosome 7pp 257 - 258 Jens Mayer, Marlies Sauter, Alexander Rácz, Daniela Scherer, Nikolaus Mueller-Lantzsch & Eckart Meese doi:10.1038/6766 Abstract|Full
text|PDF
The mouse has proven, time and time again, to be an invaluable genetic model. Nowhere is this more apparent than in the study of disease, where hundreds of conditions have been modelled and potential treatments explored. Similarly, mouse models show great promise for unravelling the genetic basis of behaviours, but the dissection of traits such as mood, personality and intelligence has proven more difficult, as behavioural variation is often subtle and the influence of genetic components difficult to measure.
The first step in identifying a gene corresponding to a trait is to identify its approximate position on one of the chromosomes -- a process called 'genetic mapping'. All maps require road signs; the more signs, the easier it is to locate the target. The 'road signs' in the mouse genome are genetic markers. The most effective way to map a gene for a particular trait is to identify a linked genetic marker and search the surrounding chromosomal region for the gene of interest. Normally, this is done by crossing two distinct inbred mouse strains that have different markers and looking for a marker that is inherited with the trait. For mapping studies, outbreeding is usually carried out for only two generations (each requiring approximately 2-3 months), but at this point, the detail is often not high enough to be informative.
To add more detail to the mouse map, Jonathan Flint (of the Institute of Molecular Medicine) and colleagues use a stock of mice outbred for 58 generations and for which the entire genealogy is known. This mouse population was established 30 years ago from crosses between eight inbred mouse strains. The researchers show that crossing out-bred mice offers a dramatic increase (about 30-fold) in map resolution over that provided by second-generation crossing of different inbred mice. The researchers demonstrate the efficacy of their method by conclusively linking two behavioural traits in the mouse associated with anxiety to narrow intervals on mouse chromosomes 1 and 12. The high resolution made possible with this approach will allow easier identification of these and other genes underlying subtle behavioural traits in a model system, and should lead to novel insights into the genetic basis of behaviour in humans.
High-resolution mapping of quantitative trait loci in outbred micepp 305 - 308 Christopher J. Talbot, Alison Nicod, Stacey S. Cherny, David W. Fulker, Allan C. Collins & Jonathan Flint doi:10.1038/6825 Abstract|Full
text|PDF
There are few cells as physically stunning as the 'hair cells' of the inner ear. Each cell has two rows of long appendages that resemble hairs (called stereocilia) that protrude from its surface -- each row is shaped like a gentle 'V', with one row slightly longer than the other. Towards the tips of the stereocilia are tip links, tiny bridges that link the ends of the cilia of the taller row with those of the shorter row. The stereocilia abut against a fairly rigid support called the tectorial membrane. Physical movement of the hairs against this membrane, which occurs when waves oscillate through the fluid of the inner ear, is translated into 'electrical' information by the hair cells, and transmitted to the brain.
As one might imagine, the integrity and function of hair cells are critical to one's ability to hear properly; previous studies have shown that mutations in genes encoding some of its components (and that of the tectorial membrane) result in deafness. The molecular 'building blocks' known to govern hair cell formation and function are also few and far between. Matthew Kelley and colleagues, of the Georgetown University School of Medicine, now report that two molecules previously implicated in determining cellular fate -- Notch and jagged-2 -- have seminal roles in hair-cell development. They concluded this upon observing that mice without jagged-2 have a significant increase in hair cell density, compared with normal mice. These mice also appear to have fewer supporting cells -- cells that are usually interspersed with hair cells. Kelley and colleagues also observed that jagged-2 is expressed by nascent hair cells of normal mice whereas Notch is expressed in supporting cells. These observations suggest that the Notch receptor extends from the supporting cell and inhibits, through its binding to jagged-2, hair-cell development in the normal mouse.
Because the Drosophila counterparts of Notch and jagged-2 have been demonstrated to mediate sensory bristle development, it has been suggested that the Drosophila bristle and the mammalian ear share a common evolutionary origin. On the other hand, as James Posakony (of the University of California) argues in an accompanying News & Views article, without 'accessory' evidence from other molecules and considering the widespread 'popularity' of Notch-signalling for determining cell fate, it may be premature to draw such conclusions. But as he also notes, it is nonetheless satisfying to get at one of the roots of the magnificent mechanosensory mosaic comprised by the inner-ear hair cells.
Notch signalling pathway mediates hair cell development in mammalian cochleapp 289 - 292 Pamela J. Lanford, Yu Lan, Rulang Jiang, Claire Lindsell, Gerry Weinmaster, Thomas Gridley & Matthew W. Kelley doi:10.1038/6804 Abstract|Full
text|PDF
Birds on a wire and tiling the inner earpp 253 - 254 James W. Posakony doi:10.1038/6760 Abstract|Full
text|PDF
Birds and humans went their separate ways -- evolutionarily speaking -- about 300 million years ago. Since then, their 'sex' chromosomes have diverged to the extent that each species appears to have a different system for determining sex. Human females have two 'X' sex chromosomes, and are therefore called the homogametic sex. Human males have an 'X' and a 'Y' sex chromosome, making them the heterogametic sex. Conversely, female birds are the heterogametic sex (they carry 'Z' and 'W' chromosomes) and the males, carrying two 'Z' chromosomes, are homogametic.
Some years ago, it was discovered that the mammalian Y chromosome carries a gene (called SRY) which is a major sex determinant -- female mice engineered to carry Sry develop testes, the signature feature of the mammalian male. There are, however, genes that operate downstream of SRY that also affect sexual characteristics; one of these appears to lie on chromosome 9, because XY human males who have a deleted portion of this chromosome fail to develop testes and exhibit sex reversal. It would seem that the gene or genes on this portion of chromosome 9 are 'dosage' sensitive -- or rather, the sexual characteristics that they affect are dependent on the dose. Inherit two copies and one develops testes; inherit one, and one does not. In contrast with the human condition, the genetic determination of sex in birds is obscure. The avian equivalent of SRY does not exist; in fact, there are no known genes that determine sex in birds.
Upon comparing the chicken genome with the human genome, however, Michael Schmid and colleagues (of the University of W¸rzburg, Germany) have not only uncovered the largest region of chromosomal conservation since the avian and mammalian lineages diverged; they also pinpoint an excellent candidate for avian sex determination -- a gene called DMRT1. Schmid and colleagues found that a stretch of genes that lie along the chicken 'Z' sex chromosome are highly similar to those of human chromosome 9, although (as would be expected) a certain degree of 'gene shuffling' has occurred. Human and chicken versions of DMRT1 lie within this region. Other studies have shown that human DMRT1 is expressed in the testes and its structure is similar to sex-regulatory genes in flies and worms. If DMRT1 turns out to be a or the critical gene that underscores sex reversal in humans who lack the relevant portion of chromosome 9, it stands to reason that it may also affect sex determination in birds -- as females carry one copy of the Z chromosome, while males carry two. While it's clear that sex isn't just for the birds, birds may end up telling us something about sex.
300 million years of conserved synteny between chicken Z and human chromosome 9pp 258 - 259 Indrajit Nanda, Zhihong Shan, Manfred Schartl, Dave W. Burt, Michael Koehler, Hans-Gerd Nothwang, Frank Grützner, Ian R. Paton, Dawn Windsor, Ian Dunn, Wolfgang Engel, Peter Staeheli, Shigeki Mizuno, Thomas Haaf & Michael Schmid doi:10.1038/6769 Abstract|Full
text|PDF